Reversible Polymerization of Low Complexity Polypeptide Sequences as a Framework
Reversible Polymerization of Low Complexity Polypeptide Sequences as a Framework
批准号:
8899608
负责人:
STEVEN L MCKNIGHT
金额:
$49.09万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2018-07-31
关键词:
AccidentsAcetylationAdoptedApplications GrantsBindingBiogenesisBiological AssayC-terminalCell ExtractsCell NucleusCellsChemicalsComplexCytoplasmic GranulesDNA Binding DomainDimensionsDiseaseEukaryotic CellFiberFilamentGelGene ExpressionGene TargetingGenesGenetic TranscriptionHealthHomeoboxHydrogelsIceIn VitroIncubatedIsoxazolesLaboratoriesLaboratory ChemicalsLateralLeucine ZippersLifeLinkLiquid substanceMammalian CellMass Spectrum AnalysisMediatingMediator of activation proteinMembraneMessenger RNAMethodsMicroscopicMolecularMonitorMutationNational Institute of Diabetes and Digestive and Kidney DiseasesNeuronsNuclearNuclear ExtractNuclear ProteinsOutcome StudyPatternPhasePhase TransitionPhysicsPolymersPrecipitationProceduresProcessProteinsRNARNA Polymerase IIRNA polymerase II largest subunitRNA-Binding ProteinsReactionReagentRelative (related person)SamplingScienceSerineStressStructureSurfaceTATA-Box Binding ProteinTestingTissue ExtractsTranscriptional ActivationTranscriptional RegulationTrinucleotide RepeatsTyrosineWorkX ray diffraction analysisX-Ray DiffractionZinc FingersbHLH Domainbasegenetic regulatory proteinin vivomedical schoolsmemberpolyglutaminepolymerizationpolypeptidered fluorescent proteinresearch studysarcomasolid state nuclear magnetic resonancetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): For upwards of 30 years it has been known that regulatory proteins involved in the control of gene expression and mRNA biogenesis contain low complexity (LC) polypeptide sequences that are intrinsically disordered. In the case of gene specific transcription factors, these LC sequences, often typified by long, homopolymeric segments of polyglutamine, have been implicated in the illusive process of transcriptional activation. It is well-understood how the DNA binding domains of transcription factors, including zinc fingers, leucine zippers, bHLH domains, and homeobox domains, facilitate direct and specific interaction between transcription factors and their target genes. By contrast, the field remains largely ignorant of the mechanisms by which the LC sequences typifying "activation domains" facilitate gene expression. In the case of proteins that regulate RNA biogenesis, similarly perplexing LC sequences are often linked to well-folded domains that mediate direct interaction with RNA substrates (including RRM, KH and pumlio domains). By serendipity, members of the McKnight laboratory discovered that a biotinylated isoxazole (b-isox) chemical is capable of reversibly co-precipitating hundreds of RNA binding proteins from cytosolic extracts. This unexpected discovery formed the starting point for experiments showing that LC sequences can reversibly polymerize into cross-beta filaments that phase transition to a hydrogel-like state. In turn, microscopic versions of these hydrogel droplets were evolved into a simplified, quantitative assay for gel retention of homotypic and heterotypic test proteins. By discovering that repeats of the sequence [G/S]Y[G/S] serve as a nucleating substrate for fiber polymerization, it was possible to test the correlative effects of mutational impediments to fiber polymerization in vitro with the ability of RNA binding proteins to move in and out of RNA granules in living cells. As a result of this work, it has been hypothesized that reversible polymerization of LC domains may represent the organizational basis for the formation of RNA granules including P-granules, stress granules, P- bodies and neuronal granules (Kato et al., 2012; Han et al., 2012). As an extension of this work nuclear extracts have been exposed to the b-isox chemical. These experiments led to the reversible precipitation of many nuclear proteins containing LC sequences, including TATA binding protein, TAF15, the largest subunit of RNA polymerase II, and components of the mediator complex. A major objective of the experiments proposed in this grant application will be the test of whether similar processes are employed to control the organization of nuclear puncta, including Cajal bodies, nuclear speckles and "transcription factories".
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A solid state conceptualization of information transfer from gene to message to protein
-
批准号:10083747
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2019
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
A solid state conceptualization of information transfer from gene to message to protein
-
批准号:10333328
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2019
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
A solid state conceptualization of information transfer from gene to message to protein
-
批准号:10561709
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2019
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
-
批准号:9021622
-
项目类别:
-
资助金额:$47.54万
-
财政年份:2014
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
-
批准号:8674809
-
项目类别:
-
资助金额:$47.54万
-
财政年份:2014
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Project 4-The ability of Circadian Genes in the VTA-Nac circuit to regulate mood
-
批准号:8114144
-
项目类别:
-
资助金额:$14.57万
-
财政年份:2010
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Discovery, characterization and preclinical development of pro-neurogenic drugs
-
批准号:8461707
-
项目类别:
-
资助金额:$118.44万
-
财政年份:2009
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Discovery, characterization and preclinical development of pro-neurogenic drugs
-
批准号:8101261
-
项目类别:
-
资助金额:$124.33万
-
财政年份:2009
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Discovery, characterization and preclinical development of pro-neurogenic drugs
-
批准号:7763981
-
项目类别:
-
资助金额:$124.8万
-
财政年份:2009
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Discovery, characterization and preclinical development of pro-neurogenic drugs
-
批准号:8305018
-
项目类别:
-
资助金额:$123.84万
-
财政年份:2009
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Discovery, characterization and preclinical development of pro-neurogenic drugs
-
批准号:7943081
-
项目类别:
-
资助金额:$126.09万
-
财政年份:2009
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Project 4-The ability of Circadian Genes in the VTA-Nac circuit to regulate mood
-
批准号:7664382
-
项目类别:
-
资助金额:$12.09万
-
财政年份:2008
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
LOGIC OF THE YEAST METABOLIC CYCLE
-
批准号:7600858
-
项目类别:
-
资助金额:$1.51万
-
财政年份:2007
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Project 4-The ability of Circadian Genes in the VTA-Nac circuit to regulate mood
-
批准号:7333117
-
项目类别:
-
资助金额:$16.45万
-
财政年份:2007
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
Administrative Core
-
批准号:7315655
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2007
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
NANOBATTERY
-
批准号:7721161
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2007
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
LOGIC OF THE YEAST METABOLIC CYCLE
-
批准号:7357901
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2006
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
NANOBATTERY
-
批准号:7598641
-
项目类别:
-
资助金额:$1.63万
-
财政年份:2006
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
NANOBATTERY
-
批准号:7357833
-
项目类别:
-
资助金额:$1.51万
-
财政年份:2005
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
LOGIC OF THE YEAST METABOLIC CYCLE
-
批准号:7180740
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2005
-
负责人:STEVEN L MCKNIGHT
-
依托单位:
海外基金